InVivoMAb anti-mouse CD31 (PECAM-1) BE0377-R001mg from Bio X Cell

Description

Bio X Cell InVivoMAb anti-mouse CD31 (PECAM-1) Monoclonal Antibody has the following reported applications: in vivo CD31 blocking, Intravital imaging, Immunofluorescence, Flow cytometry. It features greater than 95% purity, ultra-low endotoxin levels, and are preservative, stabilizer, and carrier protein-free

Product Specs
ItemInVivoMAb anti-mouse CD31 (PECAM-1)
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0377-R001mg
Antibody TypePrimary Antibody
ClonalityMonoclonal
ReactivityMouse
Clone390
IsotypeIgG2a, κ
Quantity1 mg
TargetCD31
HostRat
Purity>95%, Determined by SDS-PAGE
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
Applicationsin vivo CD31 blocking, Intravital imaging, Immunofluorescence, Flow cytometry
ImmunogenC3H/HeJ mouse hematopoietic progenitor cell line 3
NCBI Full Gene Nameplatelet/endothelial cell adhesion molecule 1
NCBI Gene AliasesCd31, PECAM-1, Pecam
Research AreaCancer Biology, Cell Migration & Adhesion, Immunology, Neuroscience, Tumor Antigens
FormatPBS, pH 7.0, Contains no stabilizers or preservatives

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) Intravital imaging allows real-time characterization of tissue resident eosinophilsCommunications biologyJanuary 1, 2019Chojnacki A, Wojcik K, Petri B, Aulakh G, Jacobsen EA, LeSuer WE, Colarusso P, Patel KD.

(2) CD31 signals confer immune privilege to the vascular endotheliumProceedings of the National Academy of Sciences of the United States of AmericaOctober 27, 2015Cheung K, Ma L, Wang G, Coe D, Ferro R, Falasca M, Buckley CD, Mauro C, Marelli-Berg FM.

(3) Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactorPloS oneJanuary 1, 2013Greineder CF, Chacko AM, Zaytsev S, Zern BJ, Carnemolla R, Hood ED, Han J, Ding BS, Esmon CT, Muzykantov VR.

(4) Involvement of endothelial PECAM-1/CD31 in angiogenesisThe American journal of pathologySeptember 1, 1997DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, et al.

(5) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular developmentDevelopment (Cambridge, England)September 1, 1994Baldwin HS, Shen HM, Yan HC, DeLisser HM, Chung A, Mickanin C, Trask T, Kirschbaum NE, Newman PJ, Albelda SM.

Be the First to Write a Review!